Next Generation T-cell Vaccine Against Coronavirus Disease (COVID-19)

Clinical trial NCT05633446 · NOT_YET_RECRUITING

Trial details

NCT number: NCT05633446
Sponsor: Gylden Pharma Ltd
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Coronavirus SARS-CoV-2 Infection COVID-19

Start date: 2025-09-01
Primary completion: 2026-06-01
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.